|
Pronunciation |
|
(FER
us GLOO koe
nate) |
|
|
U.S. Brand
Names |
|
Fergon®[OTC]; Ferralet®[OTC];
Simron®[OTC] |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Iron Salt |
|
|
Use |
|
Prevention and treatment of iron deficiency anemias |
|
|
Pregnancy Risk
Factor |
|
A |
|
|
Contraindications |
|
Hemochromatosis, hemolytic anemia; known hypersensitivity to iron
salts |
|
|
Warnings/Precautions |
|
Administration of iron for >6 months should be avoided except in patients
with continued bleeding, menorrhagia, or repeated pregnancies; avoid in patients
with peptic ulcer, enteritis, or ulcerative colitis. Anemia in the elderly is
often caused by "anemia of chronic disease" or associated with inflammation
rather than blood loss. Iron stores are usually normal or increased, with a
serum ferritin >50 ng/mL and a decreased total iron binding capacity. Hence,
the "anemia of chronic disease" is not secondary to iron deficiency but the
inability of the reticuloendothelial system to reclaim available iron
stores. |
|
|
Adverse
Reactions |
|
>10%: Gastrointestinal: Stomach cramping, constipation, nausea, vomiting,
dark stools
1% to 10%:
Gastrointestinal: Heartburn, diarrhea, staining of teeth
Genitourinary: Discoloration of urine
<1%: Contact irritation |
|
|
Overdosage/Toxicology |
|
Symptoms of overdose include acute GI irritation; erosion of GI mucosa,
hepatic and renal impairment, coma, hematemesis, lethargy, acidosis
Following treatment for fluid losses, metabolic acidosis, and shock, a severe
iron overdose may be treated with deferoxamine. Deferoxamine may be administered
I.V. (80 mg/kg over 24 hours) or I.M. (40-90 mg/kg every 8 hours). Usual toxic
dose of elemental iron: greater than or equal to 35 mg/kg. |
|
|
Drug
Interactions |
|
Absorption of oral preparation of iron and tetracyclines is decreased when
both of these drugs are given together; concurrent administration of antacids
may decrease iron absorption; iron may decrease absorption of penicillamine when
given at the same time. Response to iron therapy may be delayed in patients
receiving chloramphenicol. Concurrent administration greater than or equal to
200 mg vitamin C/30 mg elemental iron increases absorption of oral iron; milk
may decrease absorption of iron. |
|
|
Mechanism of
Action |
|
Replaces iron found in hemoglobin, myoglobin, and enzymes; allows the
transportation of oxygen via hemoglobin |
|
|
Pharmacodynamics/Kinetics |
|
Onset of hematologic response (essentially the same to either oral or
parenteral iron salts): Red blood cells form and color changes within 3-10 days,
peak reticulocytosis occurs in 5-10 days, and hemoglobin values increase within
2-4 weeks |
|
|
Usual Dosage |
|
Oral (dose expressed in terms of elemental iron):
Severe iron deficiency anemia: 4-6 mg Fe/kg/day in 3 divided doses
Mild to moderate iron deficiency anemia: 3 mg Fe/kg/day in 1-2 divided doses
Prophylaxis: 1-2 mg Fe/kg/day
Adults:
Iron deficiency: 60 mg twice daily up to 60 mg 4 times/day
Prophylaxis: 60 mg/day |
|
|
Dietary
Considerations |
|
Should be administered with water or juice on an empty stomach; may be
administered with food to prevent irritation; however not with cereals, dietary
fiber, tea, coffee, eggs, or milk |
|
|
Administration |
|
Administration of iron preparations to premature infants with vitamin E
deficiency may cause increased red cell hemolysis and hemolytic anemia,
therefore, vitamin E deficiency should be corrected if
possible |
|
|
Reference Range |
|
Therapeutic: Male: 75-175 mg/dL (SI: 13.4-31.3
mmol/L); Female: 65-165
mg/dL (SI:
11.6-29.5 mmol/L); serum iron level >300
mg/dL usually requires treatment of overdose due to
severe
toxicity |
|
|
Test
Interactions |
|
False-positive for blood in stool by the guaiac test |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
Do not prescribe tetracyclines simultaneously with iron since GI tract
absorption of both tetracycline and iron may be inhibited |
|
|
Patient
Information |
|
May color stool black, take between meals for maximum absorption; may take
with food if GI upset occurs, do not take with milk or antacids; keep out of
reach of children |
|
|
Nursing
Implications |
|
Administer 2 hours before or 4 hours after antacids
Monitor serum iron, total iron binding capacity, reticulocyte count,
hemoglobin |
|
|
Dosage Forms |
|
Amount of elemental iron is listed in brackets
Elixir (Fergon®): 300 mg/5 mL [34 mg/5 mL] with alcohol
7% (480 mL)
Tablet: 300 mg [34 mg]; 325 mg [38 mg]
Fergon®, Ferralet®: 320 mg [37
mg]
Sustained release (Ferralet® Slow Release): 320 mg [37
mg] |
|
|
References |
|
Lipschitz DA, "The Anemia of Chronic Disease," J Am Geriatr Soc, 1990,
38(11):1258-64.
Marx JJM,
"Normal Iron Absorption and Decreased Red Cell Iron Uptake in the Aged,"
Blood, 1979, 53:204-11. |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|